Also Included In: Regulatory Affairs / Drug Approvals
Article Date: 14 Oct 2011 - 2:00 PDT
email to a friend 
printer friendly 
opinions 
The Food and Drug Administration has cleared Unisense FertiliTech's EmbryoScope® for clinical use in the United States. The EmbryoScope® is a tri-gas IVF incubator with a built-in camera for automated time-lapse imaging of fertilized oocytes in a safe incubation environment from conception until the time of transfer. Embryo development may be continuously observed on the instrument interface without disturbances to embryo culture for up to 5 days.
Separate processing units control the incubation environment and the data acquisition to ensure safe and reliable operation. The EmbryoScope® allows incubation of up to 72 individual embryos in six sterile disposable EmbryoSlides® each with a capacity for 12 embryos.
CEO Jens Gundersen states "the clearance will allow the newly established USA office, FertiliTech Inc. to commence commercial activities in the US".
Unisense FertiliTech A/S was founded in 2003 as a subsidiary of Unisense A/S. The company develops and sells technology and software for improvement of assisted reproduction. The company has 34 employees and a domicile in Aarhus Denmark.
Article adapted by Medical News Today from original press release. Source: Unisense FertiliTech A/SVisit our fertility section for the latest news on this subject. Please use one of the following formats to cite this article in your essay, paper or report:
MLA
8 Dec. 2011.
Please note: If no author information is provided, the source is cited instead.
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
